Clinical trial
An Observational, Retrospective and Multicenter Study to Evaluate the Effectiveness and Safety of 1L (PEG)+ Ascorbic Acid Given for Bowel Preparation Prior to Colonoscopy in Iberia
NCT05174845 is registered in ClinicalTrials.gov with Norgine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational, Retrospective and Multicenter Study to Evaluate the Effectiveness and Safety of 1L (PEG)+ Ascorbic Acid Given for Bowel Preparation Prior to Colonoscopy in Iberia
- Lead sponsor
- Norgine
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2021
- Completion date
- March 1, 2022
- Enrollment
- 13,393 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer, colon cleansing, colon disease